Amgen (AMGN) FY2012 results: revenue $17.3 billion, up 10.8% on the year
Amgen Inc. (AMGN) reported revenue of $17.3 billion for fiscal 2012, the year ended 31 December 2012, up 10.8% on the year before. Net income was $4.3 billion, up 18.0%, and diluted earnings per share $5.52. The figures are the company's own, from the 10-K it filed with the SEC on 27 February 2013.
Revenue
$17.3 billion
+10.8% on the year
FY2007FY2012
Operating margin
32.3%
27.7% a year earlier
FY2007FY2012
Net income
$4.3 billion
+18.0% on the year
FY2007FY2012
Diluted EPS
$5.52
+36.6% on the year
FY2007FY2012
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Revenue
17,265
15,582
15,053
+10.8%
Cost of revenue
3,199
2,708
n/a
+18.1%
Gross profit
14,066
12,874
n/a
+9.3%
Gross margin
81.5%
82.6%
n/a
Research and development
3,380
3,167
2,894
+6.7%
Selling, general and administrative
4,814
4,499
3,983
+7.0%
Operating income
5,577
4,312
5,545
+29.3%
Operating margin
32.3%
27.7%
36.8%
Interest expense
1,053
610
604
+72.6%
Pre-tax income
5,009
4,150
5,317
+20.7%
Income tax
664
467
690
+42.2%
Effective tax rate
13.3%
11.3%
13.0%
Net income
4,345
3,683
4,627
+18.0%
Net margin
25.2%
23.6%
30.7%
Diluted EPS
$5.52
$4.04
$4.79
+36.6%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Operating cash flow
5,882
5,119
5,787
+14.9%
Capital expenditure
689
567
580
+21.5%
Free cash flow
5,193
4,552
5,207
+14.1%
Free cash flow margin
30.1%
29.2%
34.6%
Cash from investing
-9,990
-786
-4,152
Cash from financing
419
-674
-1,232
Depreciation and amortisation
1,088
1,060
1,017
+2.6%
Share-based compensation
362
341
353
+6.2%
Buybacks
4,607
8,315
3,786
-44.6%
Dividends paid
1,118
500
0.0
+123.6%
Diluted shares, weighted
787m
912m
965m
-13.7%
Shares outstanding at period end
756m
796m
932m
-4.9%
Balance sheet
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Shareholders' equity
19,060
19,029
23,944
+0.2%
Debt
26,529
21,428
13,362
+23.8%
Other liabilities
8,709
8,414
6,180
+3.5%
Total liabilities and equity
54,298
48,871
43,486
+11.1%
Fixed assets
5,326
5,420
5,522
-1.7%
Goodwill
12,662
11,750
11,334
+7.8%
Intangible assets
3,968
2,584
2,230
+53.6%
Investments
20,804
13,695
14,135
+51.9%
Cash and equivalents
3,257
6,946
3,287
-53.1%
Receivables
2,518
2,896
2,335
-13.1%
Inventory
2,744
2,484
2,022
+10.5%
Other assets
3,019
3,096
2,621
-2.5%
Total assets
54,298
48,871
43,486
+11.1%
10-K for the year ended 31 December 2012, filed 27 February 2013: the filing.